Ask a doctor about a prescription for CORIPREN 10 mg/10 mg FILM-COATED TABLETS
PATIENT INFORMATION LEAFLET
Coripren 10 mg/10 mg film-coated tablets
Enalapril maleate/Lercanidipine hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Coripren is a fixed combination of an ACE inhibitor (enalapril maleate) and a calcium channel blocker (lercanidipine hydrochloride), two medicines that lower blood pressure.
Coripren is used to treat high blood pressure (hypertension) in adult patients in whom lercanidipine 10 mg alone does not adequately control blood pressure. Coripren should not be used as initial treatment for hypertension.
Do not take Coripren
or obstruction of blood flow from the heart.
or untreated heart failure.
or unstable angina (chest pain that occurs at rest or worsens over time)
or during the first month after having a heart attack
o antifungals (such as ketoconazole or itraconazole)
o macrolide antibiotics (such as erythromycin, troleandomycin or clarithromycin)
o antivirals (such as ritonavir)
Warnings and precautions
Consult your doctor or pharmacist before starting to take Coripren:
If you are taking any of the following medicines, the risk of angioedema may be increased:
If you are taking any of the following medicines used to treat high blood pressure (hypertension):
Your doctor may need to monitor your kidney function, blood pressure, and blood electrolyte levels (e.g. potassium) at regular intervals.
See also the information under the heading "Do not take Coripren".
If you are going to have surgery or certain treatments soon.
If you are going to undergo any of the following procedures, inform your doctor that you are taking Coripren:
a desensitization treatment to reduce the effect of an allergy to bees or wasps.
You should inform your doctor if you think you are (or might become) pregnant or if you are breast-feeding (see the section Pregnancy, breast-feeding and fertility).
Children and adolescents
The safety and efficacy of Coripren in children under 18 years have not been established.
Other medicines and Coripren
Coripren should not be taken with certain medicines.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including medicines obtained without a prescription. This is because when Coripren is taken with other medicines, the effect of Coripren or the other medicines may be altered, or certain side effects may occur more frequently.
In particular, tell your doctor or pharmacist if you are taking any of the following medicines:
Do not take Coripren if you have taken or are currently taking sacubitril/valsartan, a medicine used to treat chronic heart failure in adults, as the risk of angioedema (rapid swelling of the throat) is increased.
If you are taking any of the following medicines, the risk of angioedema may be increased:
Your doctor may need to adjust your dose and/or take other precautions:
If you are taking an angiotensin II receptor antagonist (ARA) or aliskiren (see also the information under the headings "Do not take Coripren" and "Warnings and precautions").
Taking Coripren with food, drinks and alcohol
Pregnancy, breast-feeding and fertility
Pregnancy and fertility
You should inform your doctor if you think you are (or might be) pregnant. Your doctor will normally advise you to stop taking Coripren before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Coripren. It is not recommended during pregnancy, and you should not take it if you are more than 3 months pregnant, as it may seriously harm the unborn baby if used after the third month of pregnancy.
Breast-feeding
Coripren should not be taken during breast-feeding.
Driving and using machines
If you experience dizziness, weakness or drowsiness with this medicine, you should not drive or operate machinery.
Coripren contains lactose and sodium
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially "sodium-free".
Follow exactly the instructions of administration of this medicine given to you by your doctor or pharmacist. If you are not sure, ask your doctor or pharmacist again.
Adults:unless your doctor has told you otherwise, the recommended dose is one tablet once a day, at the same time each day. The tablet should be taken preferably in the morning, at least 15 minutes before breakfast. The tablets should be swallowed whole with water. See "Taking Coripren with food, drinks and alcohol"
Patients with kidney problems/elderly:your doctor will decide the dose of medicine that you should take, depending on how well your kidneys are working.
If you take more Coripren than you should
Do not exceed the prescribed dose. If you have taken more Coripren than you should or in case of overdose, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, telephone 91 562 04 20 or go to the hospital immediately. Take the medicine pack and this leaflet with you to show the doctor.
Taking a higher dose than recommended may cause a significant drop in blood pressure and your heart may beat irregularly or faster.
If you forget to take Coripren
If you stop taking Coripren
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. This medicine may cause the following adverse effects:
Some adverse effects can be serious.
Tell your doctor immediately if you notice any of the following adverse effects:
An allergic reaction accompanied by swelling of the face, lips, tongue, or throat that can cause difficulty breathing or swallowing;
When you start taking Coripren, you may feel weakness or dizziness, or notice that your vision becomes blurred; this is caused by a sudden drop in blood pressure, and if it happens, it will be helpful to lie down. If you are concerned, consult your doctor.
Adverse effects observed with Coripren
Frequent (may affect up to 1 in 10 people)
Cough, feeling of dizziness, headache.
Uncommon (may affect up to 1 in 100 people)
Changes in blood parameter values, such as a decrease in platelet count, increased potassium concentration in blood, nervousness (anxiety), feeling of dizziness when standing up, vertigo, rapid heartbeat, rapid or irregular heartbeat (palpitations), sudden reddening of the face, neck, or upper chest (erythema), low blood pressure, abdominal pain, constipation, feeling sick (nausea), increased liver enzyme levels, skin reddening, joint pain, increased urination frequency, feeling of weakness, fatigue, feeling of heat, ankle inflammation.
Rare (may affect up to 1 in 1,000 people)
Anemia, allergic reactions, ringing in the ears (tinnitus), fainting, dry throat, sore throat, indigestion, salty sensation on the tongue, diarrhea, dry mouth, gum inflammation, allergic reaction with swelling of the face, lips, tongue, or throat that causes difficulty swallowing or breathing, skin rash, hives, getting up at night to urinate, producing large amounts of urine, impotence.
Additional adverse effects observed with enalapril or lercanidipine alone
Enalapril
Very frequent (may affect more than 1 in 10 people)
Blurred vision, feeling of dizziness, weakness or discomfort, and cough.
Frequent (may affect up to 1 in 10 people)
Depression, headache, fainting (syncope), chest pain, dizziness due to low blood pressure, changes in heart rate, rapid heartbeats, angina, shortness of breath, alterations in taste, increased creatinine levels in blood (usually detected by analysis), high potassium levels in blood, diarrhea, abdominal pain, fatigue, rash, allergic reaction with inflammation of the face, lips, tongue, or throat with difficulty swallowing or breathing.
Uncommon (may affect up to 1 in 100 people)
Anemia (including aplastic anemia and hemolytic anemia), sudden drop in blood pressure, confusion, nervousness, drowsiness or insomnia, sensation of pins and needles in the skin or numbness, myocardial infarction (possibly caused by very low blood pressure in certain high-risk patients, including those with coronary or cerebral blood supply problems), stroke (possibly due to very low blood pressure in high-risk patients), runny nose, sore throat and hoarseness, asthma associated with chest tightness, slowed movement of food through the intestine (ileus), pancreatitis, feeling sick (vomiting), indigestion, constipation, stomach irritation (gastric irritation), dry mouth, ulcer, anorexia, itching or hives, hair loss, altered renal function, renal failure, increased sweating, high protein levels in urine (measured by analysis), muscle cramps, feeling of general discomfort, high temperature (fever), low blood sugar or sodium levels, high urea levels in blood (all measured by blood analysis), reddening, rapid or irregular heartbeats (palpitations), vertigo (feeling of dizziness), ringing in the ears (tinnitus), impotence.
Rare (may affect up to 1 in 1,000 people)
Changes in blood parameter values, such as a decrease in white blood cell count, bone marrow depression, autoimmune diseases, strange dreams or sleep disorders, "Raynaud's phenomenon" (in which the hands and feet can become intensely cold and turn white due to low blood flow), nasal inflammation, pneumonia, liver problems, such as decreased liver function, liver inflammation, jaundice (yellowing of the skin or eyes), increased liver enzyme or bilirubin levels (measured by blood analysis), erythema multiforme (red spots of different shapes that appear on the skin), Stevens-Johnson syndrome, and toxic epidermal necrolysis (a severe skin condition in which the skin turns red and forms scales, blisters, or open sores), exfoliative dermatitis/erythroderma (severe skin rash with scaling or peeling of the skin), pemphigus (small blisters filled with fluid on the skin), decreased urine production, breast tissue enlargement in males (gynecomastia), inflamed glands in the neck, armpits, or groin, fluid accumulation or other substances in the lungs (as seen on X-rays), cheek inflammation, gum inflammation, tongue, lip, or throat inflammation.
Very rare (may affect up to 1 in 10,000 people)
Intestinal inflammation (intestinal angioedema).
Frequency not known (cannot be estimated from available data)
Excessive production of antidiuretic hormone that causes fluid retention, leading to weakness, fatigue, or confusion.
A set of symptoms has been reported that may include one or more of the following: fever, blood vessel inflammation (serositis, vasculitis), muscle pain (myalgia, myositis), joint pain (arthralgia/arthritis). A rash, photosensitivity, or other skin manifestations may occur.
Lercanidipine
Some of these adverse effects can be serious. If you experience any of these adverse effects, consult your doctor.
Rare (may affect up to 1 in 1,000 people)
Chest pain (pain in the chest caused by lack of blood supply to the heart), allergic reactions (with symptoms such as itching, rash, hives), fainting.
Patient with pre-existing chest pain may experience an increase in frequency, duration, or severity of attacks associated with treatment with the group of medicines to which lercanidipine belongs. Isolated cases of myocardial infarction may be observed.
Other possible adverse effects:
Frequent (may affect up to 1 in 10 people): headache, rapid or irregular heartbeats (palpitations), sudden reddening of the face, neck, or upper chest, swelling of the ankles.
Uncommon (may affect up to 1 in 100 people): dizziness, low blood pressure, stomach burning, discomfort, stomach pain, skin rash, itching, muscle pain, increased urination, weakness or fatigue.
Rare (may affect up to 1 in 1,000 people): drowsiness, vomiting, diarrhea, hives, increased urination frequency, chest pain.
Frequency not known (cannot be estimated from available data): gum swelling, changes in liver function (detected by blood tests), cloudy fluid (when performing hemodialysis through a tube into the abdomen), swelling of the face, lips, tongue, or throat that can cause difficulty breathing or swallowing.
If any of the adverse effects worsen, or if you experience any type of adverse effect that does not appear in this prospectus, inform your doctor or pharmacist. You can consult your doctor or pharmacist for more information about adverse effects, as they have a more complete list of adverse effects.
Reporting adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the blister pack and carton after CAD. The expiration date is the last day of the month indicated.
Store Coripren in its original packaging to protect it from light and moisture. Do not store above 25°C.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Coripren
The active ingredients are enalapril maleate and lercanidipine hydrochloride.
Each film-coated tablet contains: 10 mg of enalapril maleate (equivalent to 7.64 mg of enalapril) and 10 mg of lercanidipine hydrochloride (equivalent to 9.44 mg of lercanidipine).
The other ingredients are:
Core: lactose monohydrate, microcrystalline cellulose, sodium starch glycolate type A, povidone K30, sodium bicarbonate, magnesium stearate.
Coating: hypromellose 5 cP, titanium dioxide (E171), talc, macrogol 6000.
Appearance of the product and package contents.
Coripren 10 mg/10 mg are white, circular, and biconvex tablets with a diameter of 8.5 mm.
Coripren 10 mg/10 mg is supplied in packs of 7, 14, 28, 30, 35, 42, 50, 56, 90, 98, and 100 tablets. Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Recordati Ireland Limited. Raheens East, Ringaskiddy Co. Cork. Ireland
Local representative:
Casen Recordati, S.L.
Autovía de Logroño, km. 13,300. 50180 Utebo (Zaragoza).
Manufacturer:
Recordati Industria Chimica e Farmaceutica S.p.A. – Via Matteo Civitali 1 – I-20148 Milan, Italy.
This medicine is authorized in the EEA Member States with the following names:
Italy: Coripren
Spain: Coripren
Date of the last revision of this prospectus: 07/2021
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of CORIPREN 10 mg/10 mg FILM-COATED TABLETS in October, 2025 is around 5.62 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for CORIPREN 10 mg/10 mg FILM-COATED TABLETS – subject to medical assessment and local rules.